Go to JCI Insight
Jci spelled out white on transparent.20160208
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • Fibrosis (Jan 2018)
    • Glia and Neurodegeneration (Sep 2017)
    • Transplantation (Jun 2017)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

Jci only white

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication

Review 10.1172/JCI120848

Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

Estela Area-Gomez,1 Cristina Guardia-Laguarta,2 Eric A. Schon,1,3 and Serge Przedborski2

1Department of Neurology,

2Department of Pathology and Cell Biology, and

3Department of Genetics and Development, Columbia University Medical Center, New York, New York, USA.

Address correspondence to: Serge Przedborski, Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA. Phone: 212.342.4119; Email: sp30@cumc.columbia.edu.

Find articles by Area-Gomez, E. in: JCI | PubMed | Google Scholar

1Department of Neurology,

2Department of Pathology and Cell Biology, and

3Department of Genetics and Development, Columbia University Medical Center, New York, New York, USA.

Address correspondence to: Serge Przedborski, Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA. Phone: 212.342.4119; Email: sp30@cumc.columbia.edu.

Find articles by Guardia-Laguarta, C. in: JCI | PubMed | Google Scholar | Orcid 24x24

1Department of Neurology,

2Department of Pathology and Cell Biology, and

3Department of Genetics and Development, Columbia University Medical Center, New York, New York, USA.

Address correspondence to: Serge Przedborski, Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA. Phone: 212.342.4119; Email: sp30@cumc.columbia.edu.

Find articles by Schon, E. in: JCI | PubMed | Google Scholar

1Department of Neurology,

2Department of Pathology and Cell Biology, and

3Department of Genetics and Development, Columbia University Medical Center, New York, New York, USA.

Address correspondence to: Serge Przedborski, Department of Pathology and Cell Biology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA. Phone: 212.342.4119; Email: sp30@cumc.columbia.edu.

Find articles by Przedborski, S. in: JCI | PubMed | Google Scholar | Orcid 24x24

First published January 2, 2019 - More info

Published in Volume 129, Issue 1 on January 2, 2019
J Clin Invest. 2019;129(1):34–45. https://doi.org/10.1172/JCI120848.
Copyright © 2019, American Society for Clinical Investigation

First published January 2, 2019 - Version history

Mitochondrial respiratory deficiencies have been observed in numerous neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases. For decades, these reductions in oxidative phosphorylation (OxPhos) have been presumed to trigger an overall bioenergetic crisis in the neuron, resulting in cell death. While the connection between respiratory defects and neuronal death has never been proven, this hypothesis has been supported by the detection of nonspecific mitochondrial DNA mutations in these disorders. These findings led to the notion that mitochondrial respiratory defects could be initiators of these common neurodegenerative disorders, instead of being consequences of a prior insult, a theory we believe to be misconstrued. Herein, we review the roots of this mitochondrial hypothesis and offer a new perspective wherein mitochondria are analyzed not only from the OxPhos point of view, but also as a complex organelle residing at the epicenter of many metabolic pathways.

Preview pages

Reset
Page preview
35 Page 34 Back

Continue reading with a subscription.

A subscription is required for you to read this article in full. If you are a subscriber, you may sign in to continue reading.

Already subscribed?

Click here to sign into your account.

Don't have a subscription?

Please select one of the subscription options, which includes a low-cost option just for this article.

At an institution or library?

If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).

Problems?

Please try these troubleshooting tips.

  • Purchase this article
  • $10
  • Purchasing this article will give you full access for the calendar year.
  • Purchase article
  • Purchase Site Pass
  • $25
  • This will give you access to every article on the site for 24 hours.
  • Order site pass
  • Online subscription
  • $95
  • Individual online subscriptions give you full online access for the calendar year.
  • Order Online
  • Print subscription
  • $795
  • Individual print subscriptions give you the print journal and full online access for the year.
  • Print + Online
  • JCI This Month subscription
  • $125
  • JCI This Month is a 16- to 20-page overview of the articles published each month
  • Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
  • *Price outside U.S. and Canada: $225.
  • JCI This Month + Online
Advertisement
Follow JCI: Facebook logo white Twitter logo v2 Rss icon
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts